Please Wait

Applying Filters...

Dextrans
VMF
Table View

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Dextrans

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 7 USDMF, 4 CEP/COS, 3 JDMF, 6 NDC API, 1 VMF, 3 Listed Suppliers

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 20 Europe, 6 Canada, 6 Australia, 4 South Africa, 4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 1 DKSH, 1 Nanjing Well Pharmaceutical, 10 Kirsch Pharma, 8 Actylis, 1 BASF, 3 Finar, 3 Gangwal Chemicals, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 6 Seppic

EXCIPIENTS BY APPLICATIONS

24 Parenteral, 12 Solubilizers, 5 Topical, 3 Surfactant & Foaming Agents, 3 Fillers, Diluents & Binders, 3 Emulsifying Agents, 3 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Disintegrants & Superdisintegrants